(Q30499716)

19 October 2017

1 reference

7 August 2019

1 reference

PubMed publication ID

21448170

evaluation study

1 reference

PubMed publication ID

21448170

title

Markers for the non-invasive diagnosis of mesothelioma: a systematic review (English)

1 reference

19 October 2017

1 reference

7 August 2019

1 reference

7 August 2019

1 reference

7 August 2019

1 reference

S van der Bij

1

1 reference

19 October 2017

E Schaake

2

1 reference

19 October 2017

H Koffijberg

3

1 reference

19 October 2017

J A Burgers

4

1 reference

19 October 2017

B A J M de Mol

5

1 reference

19 October 2017

K G M Moons

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

29 March 2011

1 reference

British Journal of Cancer

19 October 2017

12 April 2011

3 references

3 April 2019

19 June 2019

7 August 2019

4 references

19 October 2017

3 April 2019

19 June 2019

7 August 2019

104

1 reference

19 October 2017

8

1 reference

19 October 2017

1325-1333

1 reference

Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Proposals for a phased evaluation of medical tests

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Serum and pleural fluid biomarkers for mesothelioma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Biomarkers for malignant pleural mesothelioma: current status

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Advantages of the nested case-control design in diagnostic research

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Biomarkers for mesothelioma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Case-control and two-gate designs in diagnostic accuracy studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Sources of variation and bias in studies of diagnostic accuracy: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Characteristics of good diagnostic studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Toward complete and accurate reporting of studies of diagnostic accuracy. The STARD initiative

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Empirical evidence of design-related bias in studies of diagnostic tests

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

Assessment of diagnostic tests when disease verification is subject to selection bias

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

The efficacy of diagnostic imaging

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078590

A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.104

Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.104

Accuracy and reproducibility of pleural effusion cytology

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.104

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

21 January 2018

1 reference

12 December 2020

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

12 December 2020

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

1 reference

12 December 2020

The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis

1 reference

12 December 2020

Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?

1 reference

12 December 2020

Criteria for scientific evaluation of novel markers: a perspective

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2011.104

1 reference

Dimensions Publication ID

19 October 2017

1025943237

0 references

Fatcat ID

release_kbk7frzki5edfpw4bbdnkzudmi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kbk7frzki5edfpw4bbdnkzudmi

24 November 2022

mapped directly with Wikidata item

1 reference

19 October 2017

PubMed publication ID

21448170

1 reference